Download the conference brochureLearn more about the Summit, who you will meet, the schedule-at-a-glance, and more.

Begin Scheduling Your 1:1 Partnering Meetings

BioCentury-BayHelix East-West Summit 2024 Details

For three decades BioCentury has helped biotech executives and investors make business critical decisions and build larger networks with peers across the innovation ecosystem.

Why Singapore?
In 2024, BioCentury and BayHelix bring the 3rd East-West Biopharma Summit to Singapore, where 20 years of government-led investment in science, talent and infrastructure has set the stage for the life sciences industry to carry the ball forward. With VC money now pouring into Singapore, new investment opportunities are emerging, both in Singapore and across Asia. 

A Pan-Asia Event:
For Western innovators and investors, Singapore is also the gateway to Asia. It is a turf-neutral hub to meet with industry leaders from China, Japan, South Korea, India, and Southeast Asia.

See for yourself:
Join us in Singapore for two-plus days of C-level networking, partnering and debate. 

Plus, two days of company presentations and a day-long poster session to showcase Singapore's science and technology with commercial potential.

This exclusive event is designed for VCs, CEOs, CFOs, CBOs and decision-makers from Asia and the West who are shaping the future of biopharma innovation. 

Register today: 
Early Bird Rates expire January 26, 2024. 

BioCentury-BayHelix East-West Healthcare Summit Preview

BioCentury-BayHelix East-West Summit Podcast: Preview

Listen to "BioCentury This Week" for a preview of the BioCentury-BayHelix East-West Summit Summit with special guests joining Executive Editor and Head of Daily Global Intelligence & Host, "BioCentury This Week" Podcast, Jeff Cranmer.

Organizing Committee

Steve Yang, Ph.D.
Co-CEO
WuXi AppTec
Christine Brennan
Managing Director
Vertex Ventures
Piers Ingram, Ph.D.
Co-Founder & CEO
Hummingbird Bioscience
Khoo Shih, Ph.D.
CEO
ClavystBio
Amy Schulman
Managing Partner
Polaris Partners
André Andonian
Chair of Asia Pacific and Strategic Advisor
Flagship Pioneering
Moreright-arrow

Speakers

Beh Kian Teik
CEO
Singapore National Research Foundation, and Chairman of Singapore's Biotech Working Committee
Ansbert Gadicke, M.D.
Managing Partner
MPM BioImpact
Sharon Chan, DPhil
VP, Asia Pacific
JLABS, Johnson & Johnson
Art Pappas
Managing Partner
Pappas Capital
Jenny Yang, Ph.D.
Senior Director, Global Search & Evaluation
Novo Nordisk
Douglas Williams, Ph.D.
CEO
TriArm Therapeutics
Moreright-arrow

Sponsors

Sponsorship opportunities availableSpeak with a BioCentury representative today

2024 Presenting CompaniesInterested in pitching your story to top investors and BD&L leaders?